Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 6/2014

Open Access 01-12-2014 | Commentary

Ventilator-associated tracheobronchitis: pre-emptive, appropriate antibiotic therapy recommended

Authors: Donald E Craven, Jana Hudcova, Yuxiu Lei

Published in: Critical Care | Issue 6/2014

Login to get access

Abstract

Nseir and colleagues presented data from a large multicenter study of patients with ventilator-associated tracheobronchitis (VAT), demonstrating that appropriate antibiotic therapy for VAT was an independent predictor for reducing transition to pneumonia (ventilator-associated pneumonia, or VAP). These data added to the growing evidence supporting the use of appropriate antibiotic therapy for VAT as a standard of care to prevent VAP and improve patient outcomes.
Appendix
Available only for authorised users
Literature
1.
Nseir S, Martin-Loeches I, Makris D, Jaillette E, Karvouniaris M, Valles J, Zakynthinos E, Artigas A: Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia. Crit Care. 2014, 18: R129-10.1186/cc13940.CrossRef
2.
Nseir S, Di Pompeo C, Pronnier P, Beague S, Onimus T, Saulnier F, Grandbastien B, Mathieu D, Delvallez-Roussel M, Durocher A: Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J. 2002, 20: 1483-1489. 10.1183/09031936.02.00012902.CrossRef
3.
Nseir S, Favory R, Jozefowicz E, Decamps F, Dewavrin F, Brunin G, Di Pompeo C, Mathieu D, Durocher A: Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care. 2008, 12: R62-10.1186/cc6890.CrossRef
4.
Palmer LB, Smaldone GC, Chen JJ, Baram D, Duan T, Monteforte M, Varela M, Tempone AK, O’Riordan T, Daroowalla F, Richman P: Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med. 2008, 36: 2008-2013. 10.1097/CCM.0b013e31817c0f9e.CrossRef
5.
Craven DE, Lei Y, Ruthazer R, Sarwar A, Hudcova J: Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. Am J Med. 2013, 126: 542-549. 10.1016/j.amjmed.2012.12.012.CrossRef
6.
Agrafiotis M, Siempos II, Falagas ME: Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir Med. 2010, 104: 325-336. 10.1016/j.rmed.2009.09.001.CrossRef
7.
Dallas J, Skrupky L, Abebe N, Boyle WA, Kollef MH: Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population. Chest. 2011, 139: 513-518. 10.1378/chest.10-1336.CrossRef
8.
Bouza E, Granda MJ, Hortal J, Barrio JM, Cercenado E, Muñoz P: Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients. Intensive Care Med. 2013, 39: 1547-1555. 10.1007/s00134-013-2997-6.CrossRef
9.
Kollef MH, Hamilton CW, Montgomery AB: Aerosolized antibiotics: do they add to the treatment of pneumonia?. Curr Opin Infect Dis. 2013, 26: 538-544. 10.1097/QCO.0000000000000004.CrossRef
10.
Abu-Salah T, Dhand R: Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update. Adv Ther. 2011, 28: 728-747. 10.1007/s12325-011-0051-z.CrossRef
11.
Montgomery AB, Vallance S, Abuan T, Tservistas M, Davies A: A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI Investigational eFlow Inline Nebulizer System in mechanically ventilated patients. J Aerosol Med Pulm Drug Deliv 2014, Epub ahead of print.,
12.
Craven DE, Hudcova J, Craven KA, Scopa C, Lei Y: Antibiotic treatment of ventilator-associated tracheobronchitis: to treat or not to treat? Curr Opin Crit Care 2014, Epub ahead of print.,
13.
Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW: Long-term cognitive impairment after critical illness. N Engl J Med. 2013, 369: 1306-1316. 10.1056/NEJMoa1301372.CrossRef
14.
Herridge M, Cameron JI: Disability after critical illness. N Engl J Med. 2013, 369: 1367-1369. 10.1056/NEJMe1309482.CrossRef
15.
Unroe M, Kahn JM, Carson SS, Govert JA, Martinu T, Sathy SJ, Clay AS, Chia J, Gray A, Tulsky JA, Cox CE: One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: a cohort study. Ann Intern Med. 2010, 153: 167-175. 10.7326/0003-4819-153-3-201008030-00007.CrossRef
16.
Rodríguez A, Póvoa P, Nseir S, Salluh J, Curcio D, Martín-Loeches I: Incidence and diagnosis of ventilator-associated tracheobronchitis (VAT) in the intensive care unit: an international online survey. Crit Care. 2014, 18: R32-10.1186/cc13725.CrossRef
17.
Craven DE, Hjalmarson KI: Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box. Clin Infect Dis. 2010, 51 (Suppl 1): S59-S66. 10.1086/653051.CrossRef
Metadata
Title
Ventilator-associated tracheobronchitis: pre-emptive, appropriate antibiotic therapy recommended
Authors
Donald E Craven
Jana Hudcova
Yuxiu Lei
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0627-5

Other articles of this Issue 6/2014

Critical Care 6/2014 Go to the issue

Research

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

Letter

Correlation of early over-sedation with clinical outcomes in mechanically ventilated patients: further studies are needed

Research

Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients

Commentary

Acute kidney injury survivors should have long-term follow-up

Commentary

Early identification of patients at risk of long-term critical illness-associated physical disability: is it possible?

Commentary

A lesson on induction of hypothermia and measurement of efficacy